ArticleEmerging microbes & infections2026
The mouse-lethal H5N1 influenza virus carrying the PB2-384L/443R/460M characteristics acquired in avian hosts can effectively utilize human ANP32A/B proteins.
Article in Emerging microbes & infections, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The species-specific acidic nuclear phosphoprotein 32 kDa members (ANP32A/B) play a key role in restricting the function of avian influenza virus polymerase in mammalian host. Avian influenza viruses, upon replicating in humans, may acquire critical amino acid substitutions in the polymerase basic 2 (PB2) protein (e.g. E627 K and D701N) that enhance the viral polymerase's functional compatibility with human ANP32A and ANP32B proteins, thereby augmenting viral replication efficiency and increasing pathogenic potential in humans. However, certain H5N1 avian influenza viruses have demonstrated the capacity to establish productive human infections in the absence of the canonical PB2-627 K or PB2-701N adaptive mutations; the underlying molecular mechanism remains incompletely characterized. In this study, we found that the two H5N1 viruses, namely A/chicken/LN/SD035/2018 (LN35) and A/duck/JL/S1261/2019 (JL261), were genetically similar, but their pathogenicity for mice was different. By evaluating a series of single-gene reassortant viruses and mutants in mice, we confirmed that the PB2-384L/443R/460M characteristics are crucial for LN35 to maintain high lethality in mice. We further revealed that the polymerase of H5N1 avian virus bearing PB2-384L/443R/460M signature could efficiently utilize human ANP32A/B. Moreover, we found that this PB2-384L/443R/460M signature positively regulates H5N1 vRNP-human ANP32A/B interaction and vRNP assembly. Our findings indicate that key amino acid substitutions in the PB2 gene of the H5N1 virus may emerge in avian host and then augment its capacity to interact with human ANP32A/B protein, underscoring the substantial zoonotic and public health risks associated with continued circulation and evolution of H5N1 in avian populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.